Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity
| Autor: | John Sylvester, Wayne M. Butler, Peter Grimm, Joshua L. Reed, Zachariah A. Allen, Gregory S. Merrick, Jonathan A. Khanjian |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
Time Factors medicine.medical_treatment Brachytherapy Rectum Iodine Radioisotopes Prostate Humans Medicine Dosimetry Radiology Nuclear Medicine and imaging Radioisotopes Centimeter business.industry Prostatic Neoplasms Dose-Response Relationship Radiation Radiotherapy Dosage 125i seed Treatment Outcome medicine.anatomical_structure Oncology Rectal wall Tomography X-Ray Computed business Nuclear medicine Postimplant dosimetry Palladium Prostate brachytherapy |
| Zdroj: | Brachytherapy. 10:35-43 |
| ISSN: | 1538-4721 |
| DOI: | 10.1016/j.brachy.2009.12.001 |
| Popis: | PURPOSE: In this study, the effect of prostate brachytherapy seed activity on postimplant rectal dosimetry was evaluated in Pro-Qura (Prostate Brachytherapy Quality Assurance; Seattle, WA) proctored, community-based programs. METHODS AND MATERIALS: Twenty-three hundred patients (1563 iodine-125 ( 125 I) and 737 palladium-103 ( 103 Pd)) from 78 brachytherapists with postimplant rectal dosimetry were identified. Seed activity was stratified into three tertiles for each isotope ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|